tiprankstipranks
Advertisement
Advertisement

HK:3692 Stock Latest News

Hansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug
Company AnnouncementsHansoh Pharma Wins NMPA Breakthrough Status for Fourth-Gen Lung Cancer Drug
6d ago
3692
Hansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles
PremiumCompany Announcements
Hansoh Pharmaceutical Reshuffles Company Secretary and Compliance Roles
11d ago
3692
Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod for Trial of New KRAS-Targeting Cancer Drug
13d ago
3692
Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC
PremiumCompany Announcements
Hansoh Pharmaceutical Wins Breakthrough Therapy Status for Esophageal Cancer ADC
16d ago
3692
Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases
PremiumCompany Announcements
Hansoh Pharmaceutical Expands RSU Share Pool With Market Purchases
27d ago
3692
Hansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
PremiumCompany AnnouncementsHansoh Hands KiOmed Osteoarthritis Licence to Hengrui in Strategic Refocus
27d ago
3692
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
Premium
Company Announcements
Hansoh Pharma Wins China Nod for Trials of New Hypertension Drug HS-10522
27d ago
3692
Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
Premium
Company Announcements
Hansoh Pharma Wins Breakthrough Therapy Designation in China for Prostate Cancer ADC
27d ago
3692
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
PremiumCompany Announcements
Hansoh Pharmaceutical Sets Final 2025 Dividend at HKD 0.20 Per Share
28d ago
3692
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
PremiumCompany Announcements
Hansoh Pharma Grants 5 Million RSUs to Staff Under Post-IPO Incentive Scheme
28d ago
3692
Hansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme
PremiumCompany Announcements
Hansoh Pharma Overhauls Equity Incentives With New 2026 Share Scheme
28d ago
3692
Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo
PremiumCompany Announcements
Hansoh Pharma Wins China Breakthrough Therapy Status for Lung Cancer ADC Combo
1M ago
3692
Hansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
PremiumCompany AnnouncementsHansoh Pharma Delivers Double-Digit 2025 Growth as Innovative Drugs Drive Earnings and Pipeline Wins
2M ago
3692
Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025
Premium
Company Announcements
Hansoh Pharmaceutical Proposes HKD 0.20 Final Dividend for 2025
2M ago
3692
Hansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio
Premium
Company Announcements
Hansoh Wins Third China Indication for XINYUE, Expanding Autoimmune Portfolio
2M ago
3692
Hansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod to Begin Trials of New Cancer Drug HS-10587
2M ago
3692
Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Nod to Begin Trials for New PNH Drug
2M ago
3692
Hansoh Pharma Sets March 29 Board Meeting to Approve 2025 Results and Consider Final Dividend
PremiumCompany Announcements
Hansoh Pharma Sets March 29 Board Meeting to Approve 2025 Results and Consider Final Dividend
2M ago
3692
Hansoh Pharma Wins NMPA Review Nod for New Targeted Lung Cancer Therapy
PremiumCompany Announcements
Hansoh Pharma Wins NMPA Review Nod for New Targeted Lung Cancer Therapy
3M ago
3692
Hansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib
PremiumCompany AnnouncementsHansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib
3M ago
3692
Hansoh Pharmaceutical Raises HK$4.68 Billion via Zero-Coupon Convertible Bonds to Fuel Drug R&D
Premium
Company Announcements
Hansoh Pharmaceutical Raises HK$4.68 Billion via Zero-Coupon Convertible Bonds to Fuel Drug R&D
4M ago
3692
Hansoh Pharmaceutical to Raise HK$4.68 Billion via Zero-Coupon Convertible Bonds
Premium
Company Announcements
Hansoh Pharmaceutical to Raise HK$4.68 Billion via Zero-Coupon Convertible Bonds
4M ago
3692

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >